Skip to main content
PLOS One logoLink to PLOS One
. 2020 Dec 10;15(12):e0243751. doi: 10.1371/journal.pone.0243751

Determinants of community members’ willingness to donate stool for faecal microbiota transplantation

Melissa K Hyde 1,*, Barbara M Masser 1,2
Editor: Rick K Wilson3
PMCID: PMC7728237  PMID: 33301497

Abstract

Universal stool banks rely on, but face difficulties recruiting, community volunteers to donate stool for faecal microbiota transplantation (FMT) to effectively treat recurrent Clostridioides difficile. This study sought to identify determinants of community members’ willingness to donate stool to guide donor recruitment. 397 Australian residents (52% male, 47% 21–30 years, 63% university educated) completed a survey to gauge willingness to donate stool, bowel habits, information needs, attitudes, barriers, and motives for donation. Most reported regular bowel movements (BMs; 90%), morning BMs (63%), BMs ≤5 minutes duration (67%), and some discomfort doing BMs in public restrooms (69%). Less than half were willing to donate stool in-centre (45% willing) or at home (48%). Important information needs identified by >80% were convenience and travel requirements associated with donation. Main barriers were logistics, capabilities to donate, disgust (e.g., donation process), and discomfort (e.g., privacy). The main motivator was altruism, with compensation secondary. Linear regression models identified less discomfort doing BMs in public restrooms (β = -0.15), understanding benefits to patients (β = 0.15), placing less importance on understanding the donation process (β = -0.13), and positive attitudes (β = 0.56) as determinants of willingness to donate in-centre. Understanding benefits to self (β = 0.11) and patients (β = 0.24), placing less importance on understanding the donation purpose (β = -0.19), and positive attitudes (β = 0.50) determined willingness to donate at home. Stool banks should consider donor’s bowel habits, comfort donating in-centre, and information needs early in recruitment; and implement flexible logistics for potential donors who face time constraints and limited access to stool banks.

Introduction

Faecal microbiota transplantation (FMT) is a highly effective treatment for the 20%-30% of patients who develop recurrent Clostridioides difficile infection (CDI) after first-line treatment with antibiotics [1], and shows promise for other inflammatory bowel diseases and gastrointestinal conditions [24]. Successful treatment of recurrent CDI and prevention of recurrence occurs for 70–90% of FMT recipients [1], as well as health care savings following FMT (e.g., 42% reduction in hospital costs in the first year) [5], and substantially improved quality of life [6]. Widespread availability of this increasingly in-demand treatment depends on the availability of willing stool donors. Traditionally, stool has been donated by someone known to the patient. More recently, volunteer donors from universal stool banks are the preferred and more advantageous approach due to stringent screening and fewer delays in access to treatment [1,7]. However, recruitment of volunteer stool donors is challenging and costly [8], numbers of eligible donors rarely meet demand [1], and little information is available about what factors influence people’s decisions to donate stool.

Helping patients and extending current blood donor activities to try stool donation are identified key motivators of stool donors [9], although other research shows that stool donor’s altruistic behaviour (volunteering, donating blood) was not associated with donation frequency or quantity of donations processed as treatments [10]. Medical students [11], and university-affiliated health professionals, students and staff [12], who had greater awareness of FMT or its benefit for patients were more willing to donate stool (58% highly willing to donate [12]). Willingness was predicted by male gender, altruism, preference for economic compensation, positive attitudes towards FMT, blood donation, having considered organ donation, and less concern about barriers to donation (stool collection as unpleasant, invasive screening process, monthly donation as a large commitment) [12]. One-third identified logistics such as the required time commitment and delivery of their donation, as the main barriers to stool donation [12]. Logistics, including the required donation frequency and duration, also prevent potential community donors from progressing beyond pre-screening [8,1316].

Individual bowel habits such as the frequency, timing, and duration of bowel movements (BM), as well as discomfort donating outside the home environment (e.g., at a collection facility), likely also impact logistics and donation willingness, but their impact has not been considered. Moreover, there is variability in stool collection procedures with some facilities allowing donors to collect stool at home and transport it to a facility [17,18], while others adhere to biosafety regulations that require stool collection to occur in a designated room at the facility [19]. As such, it is important to consider both home and in-centre donation. Regarding bowel habits, general population studies suggest that most people fall within the range of 3 BMs per day to 3 per week, and have morning BMs [2022], although reports vary depending on measures used [20,23,24], and gender or age differences [2123,25]. Patients who failed to give a sample for stool banking either could not do a BM, or did a BM outside the designated collection period [26]. Further, consumer surveys report the general public’s discomfort doing a BM away from home due to lack of privacy or embarrassment, with males more comfortable using a public restroom for BMs than females [27].

Given the increasing reliance on community donors to support universal stool banks and FMT programs, the aims of this study were to provide guidance for donor recruitment by examining willingness to donate stool in-centre and at home, and identifying potential contributors to this willingness, particularly bowel habits, information needs, motives and barriers to donation. In doing so, this study also provides the first insight into the Australian community’s willingness to donate stool.

Materials and methods

Human Research Ethics Approval was obtained from The University of Queensland (Approval number 2020000029) and Australian Red Cross Lifeblood (Approval number 2020#03) committees. Participants indicated their consent to participate by selecting a response confirming their consent prior to commencing a survey and by submission of a survey.

This is a cross-sectional study using data obtained from Australian residents aged ≥18 years who completed an online survey (Qualtrics platform). Residents were recruited via the online crowdsourcing platform, Prolific, which connects researchers with community members who have registered to participate in research and receive monetary compensation for their time. Prolific verifies and checks the quality of data provided by participants to ensure that it is high quality. Australian residents registered on Prolific (approximately 1200 active in the past 90 days; 48% male) initially received a notification about the study “Understanding community attitudes towards stool donation”, and were invited to complete a short pre-screening survey to determine if they were eligible to participate. Eligibility criteria were as follows: currently living in Australia; aged 18 years or older; consider yourself to be in good health with no current medical conditions; consider yourself to be of normal weight; are not currently taking medication for a medical condition; do not currently have a chronic digestive disorder or condition that may affect how often you do a bowel movement; and eligible to donate blood.

While the eligibility criteria employed in this study broadly reflected screening criteria for recruitment of community donors to stool banks, it should be noted that there is variability in screening criteria globally. For instance, the Australian Consensus Working Group [28] and the Standard for Faecal Microbiota Transplant Products (TGO 105) [29] states that generally donors should be aged between 16–60 years and donors over the age of 50 should have completed bowel cancer screening. The international consensus conference on stool banking for FMT [17] states younger individuals aged below 50 years (or below 60 years if bowel cancer screening has been completed) are preferred as potential donors. The FMT-standardization Study Group’s Nanjing consensus on methodology of washed microbiota transplantation [19] recommends healthy adults and adolescents, preferably those aged 6–24 years, as FMT donors.

Once participants self-selected into the study and confirmed their eligibility (S1 Appendix), those eligible provided consent to participate by selecting the yes response to confirm that they had read a participant information sheet, understood the topic of the research, understood that their data would be reported in a de-identified form, and agree to participate. Upon consenting, residents were then invited to complete the main survey. Surveys were completed from February 17th to March 18th, 2020, and participants were compensated £6.00 per hour for their time. University human research ethics committee approval was obtained prior to study commencement. Data from a sub-group of these participants that examines a different set of variables regarding the role of ambivalence in eligible blood donors’ decisions to donate stool has been published elsewhere [30].

Survey questions were drawn from published studies on stool donation or from other contexts and adapted. Participant characteristics were assessed using one-item measures of age (in years), gender, education, BMI (kg/m2), current blood donor and registered organ donor status. Self-reports of bowel habits comprised six items that measured frequency of BMs [27,31,32]: whether BMs were regular and occurred every day (yes, no, sometimes), and on average, the daily and weekly frequency of BMs (free-text); and two items assessed when in the day participants usually or most often had a BM (morning, midday, afternoon, evening, night) [27], and approximate duration of BMs from start to finish (minutes). A 4-item sub-scale [33] assessed discomfort having a BM in a public restroom (e.g., I cannot use the toilet in a public restroom to have a BM when other people are around), 0 none of the time to 4 all of the time, Cronbach’s α = 0.91.

Awareness of CDI and FMT prior to the study was established using two items, scored yes, no, unsure [32]. Following this, all participants read short paragraphs describing CDI [3436], FMT [3739], and typical requirements for donors and donation to ensure equivalency of knowledge before indicating willingness to donate (S2 Appendix). Willingness to donate to a stool bank was measured via one-item scales across scenarios that varied location: at a collection facility (in-centre) (unknown recipient), at home and deliver to a facility (unknown recipient); and purpose: for a loved one, research, or to develop new treatment(s). Participants indicated their willingness on a slider bar from 0 to 100, where a score of 0 indicated participants were not at all willing to donate, and a score of 100 indicated participants were extremely willing to donate (S1 Appendix). Those indicating willingness to donate stool in-centre or at home (i.e., a score on the scale mid-point of 50 or above) were then presented with questions that asked them to report using free-text responses how often and for how long they would be willing to donate in each scenario. Participants were given an example of how to format their response to ensure clarity and consistency of responses across participants (S1 Appendix). For example, a person willing to give 2 times a day for 1 week would write “2 times a day” in the first free-text box and “1 week” in the second free-text box. One author (MKH) manually coded the free-text responses separately for frequency (e.g., daily and 1 time a day were coded as “1 time a day”) and length of time (e.g., 2 weeks and a fortnight were coded as “2 weeks”). These codes were then manually combined (e.g., “1 time a day for 2 weeks”). Given there was great variability in responses and some were unclear, responses were further coded as: a set number of times, daily, weekly, monthly, yearly, other, or unclear.

Following indicating their willingness to donate, participants rated the importance of nine information items when considering stool donation (e.g., understanding how donating stool could help patients), 1 not at all important to 7 very important [40]. Participants self-reported their general attitudes towards stool donation (no opinion to very positive) and their attitudes towards personally donating (negative, neutral, positive) on 1-item scales [41]. Motives and barriers to donation were identified using two free-text response questions “if you were willing to donate to a stool bank for a person you did not know who was sick with CDI, what would be your main reason(s) for doing so?” and “what would stop you or make it difficult to donate?”.

Statistical analysis

Categorical (frequencies, percentages) and continuous (means, standard deviations) variables were summarised using descriptive statistics. Cronbach’s alpha ≥0.70 confirmed scale reliability. Differences in responses by category were explored using chi-square tests of independence with follow-up z-tests, and continuous variables were examined using univariate analysis of variance with post-hoc Bonferroni tests. Linear regression analysis identified determinants of willingness, with p ≤0.05 indicating significance. Exploratory analyses identified potential differences in responses by gender (male, female), age group (<21, 21–30, 31–40, 41–50, >50) [12], university education (yes, no), discomfort doing BMs in public restrooms (none, some/a little, most/all, of the time), blood and organ donor status (yes, no/unsure).

Free-text qualitative responses were analysed using thematic analysis [42]. Two coders independently generated themes, and these were compared and refined, with disagreements resolved by a third coder. Themes described by ≥10% of participants are reported.

Results

A total of 758 Australian residents received survey invitations, of which 491 met study criteria (64.7% eligible). Of those eligible, 397 provided complete data for analysis (81% response rate). Participants mean age was 29.59 years (SD = 9.33, 18–73). Mean BMI was 24.04 (SD = 3.86), and 65% were in the ‘healthy’ BMI range (18.5 to 24.9).

Almost 90% reported regular BMs. Over half had one BM per day and one-third had seven BMs per week, most had morning BMs, of ≤5 minutes duration. On average, participants experienced some discomfort having BMs in public restrooms (M = 2.71, SD = 1.23, range 1–5, higher scores indicating more discomfort); 69% experienced discomfort at least a little of the time. Table 1 shows participant’s bowel habits overall and by gender and age group. More females (vs. males) had morning BMs and took ≤5 minutes doing so. Fewer participants <21 years had morning BMs, and more participants in this age group had BMs in the evening and at night (vs. other age groups). Significantly more females (vs. males) experienced discomfort most to all of the time having BMs in public restrooms.

Table 1. Participant’s frequency, duration and timing of bowel movements by gender and age (N = 397).

Gender Age (years)
Bowel habits All n (%) Male n (%) Female n (%) <21 n (%) 21–30 n (%) 31–40 n (%) 41–50 n (%) >50 n (%)
Regular BM
Yes 355 (89.4) 188 (90.4) 167 (88.4) 55 (88.7) 165 (89.2) 88 (89.8) 35 (89.7) 12 (92.3)
No 10 (2.5) 7 (3.4) 3 (1.6) 1 (1.6) 7 (3.8) 1 (1.0) 1 (2.6) 0 (0.0)
Sometimes 32 (8.1) 13 (6.3) 19 (10.1) 6 (9.7) 13 (7.0) 9 (9.2) 3 (7.7) 1 (7.7)
Between sub-group comparison p = 0.216 p = 0.921
Daily frequency of BMs
<1 20 (5.0) 10 (4.8) 10 (5.3) 2 (3.2) 12 (6.5) 5 (5.1) 1 (2.6) 0 (0.0)
1 only 231 (58.2) 118 (56.7) 113 (59.8) 33 (53.2) 107 (57.8) 52 (53.1) 28 (71.8) 11 (84.6)
1–2 14 (3.5) 5 (2.4) 9 (4.8) 1 (1.6) 8 (4.3) 3 (3.1) 2 (5.1) 0 (0.0)
2 only 96 (24.2) 53 (25.5) 43 (22.8) 16 (25.8) 44 (23.8) 29 (29.6) 5 (12.8) 2 (15.4)
>2 36 (9.1) 22 (10.6) 14 (7.4) 10 (16.1) 14 (7.6) 9 (9.2) 3 (7.7) 0 (0.0)
Between sub-group comparison p = 0.530 p = 0.419
Weekly frequency of BMs
<7 95 (23.9) 41 (19.7) 54 (28.6) 12 (19.4) 50 (27.0) 23 (23.5) 8 (20.5) 2 (15.4)
7 only 112 (28.2) 59 (28.4) 53 (28.0) 14 (22.6) 47 (25.4) 26 (26.5) 20 (51.3) 5 (38.5)
7–14 83 (20.9) 48 (23.1) 35 (18.5) 15 (24.2) 42 (22.7) 16 (16.3) 6 (15.4) 4 (30.8)
14 only 56 (14.1) 30 (14.4) 26 (13.8) 10 (16.1) 25 (13.5) 18 (18.4) 1 (2.6) 2 (15.4)
>14 51 (12.8) 30 (14.4) 21 (11.1) 11 (17.7) 21 (11.4) 15 (15.3) 4 (10.3) 0 (0.0)
Between sub-group comparison p = 0.276 p = 0.119
Timing of usual BM
In the morning 251 (63.2) 121 (58.2) 130 (68.8)a 24 (38.7)d 119 (64.3) 70 (71.4) 25 (64.1) 13 (100)
Midday 29 (7.3) 20 (9.6) 9 (4.8) 4 (6.5) 18 (9.7) 5 (5.1) 2 (5.1) 0 (0.0)
In the afternoon 53 (13.4) 33 (15.9) 20 (10.6) 10 (16.1) 24 (13.0) 13 (13.3) 6 (15.4) 0 (0.0)
In the evening 50 (12.6) 30 (14.4) 20 (10.6) 16 (25.8)e 21 (11.4) 8 (8.2) 5 (12.8) 0 (0.0)
At night 14 (3.5) 4 (1.9) 10 (5.3) 8 (12.9)f 3 (1.6) 2 (2.0) 1 (2.6) 0 (0.0)
Between sub-group comparison p = 0.023 p < 0.001
Timing of additional BM (if more than one) (n = 258)
In the morning 48 (18.6) 29 (19.6) 19 (17.3) 10 (22.7) 15 (12.5) 16 (24.2) 7 (31.8) 0 (0.0)
Midday 27 (10.5) 13 (8.8) 14 (12.7) 7 (15.9) 14 (11.7) 4 (6.1) 1 (4.5) 1 (16.7)
In the afternoon 74 (28.7) 41 (27.7) 33 (30.0) 8 (18.2) 39 (32.5) 18 (27.3) 7 (31.8) 2 (33.3)
In the evening 71 (27.5) 40 (27.7) 31 (28.2) 11 (25.0) 28 (23.3) 24 (36.4) 6 (27.3) 2 (33.3)
At night 38 (14.7) 25 (16.9) 13 (11.8) 8 (18.2) 24 (20.0) 4 (6.1) 1 (4.5) 1 (16.7)
Between sub-group comparison p = 0.668 p = 0.100
Duration of BM (minutes) (n = 394)
≤ 5 264 (67.0) 117 (56.8) 147 (78.2)b 37 (60.7) 114 (62.0) 71 (72.4) 30 (78.9) 12 (92.3)
6–10 96 (24.2) 63 (30.6) 33 (17.6) 17 (27.9) 48 (26.1) 22 (22.4) 8 (21.1) 1 (7.7)
>10 34 (8.6) 26 (12.6) 8 (4.3) 7 (11.5) 22 (12.0) 5 (5.1) 0 (0.0) 0 (0.0)
Between sub-group comparison p < 0.001 p = 0.067
Discomfort doing a BM in a public restroom
Discomfort none of the time (1) 125 (31.5) 72 (34.6) 53 (28.0) 14 (22.6) 56 (30.3) 36 (36.7) 13 (33.3) 6 (46.2)
Discomfort a little/some of the time (2) 190 (47.9) 105 (50.5) 85 (45.0) 28 (45.2) 92 (49.7) 47 (48.0) 16 (41.0) 7 (53.8)
Discomfort most/all of the time (3) 82 (20.7) 31 (14.9) 51 (27.0)c 20 (32.3) 37 (20.0) 15 (15.3) 10 (25.6) 0 (0.0)
Between sub-group comparison p = 0.011 p = 0.121

BM = Bowel movement. Bolded numbers indicate a statistically significant difference.

a female vs. male, z = 2.2, p = 0.0287.

b female vs. male, z = 4.5, p < 0.001.

c female vs. male, z = 3.0, p = 0.003.

d < 21 years vs. 21–30 (z = 3.5, p <0.001), 31–40 (z = 4.1, p <0.001), 41–50 (z = 2.5, p = 0.013), or 50 (z = 4.0, p <0.001) years.

e < 21 years vs. 21–30 (z = 2.7, p = 0.006), 31–40 (z = 3.0, p = 0.002), or 50 (z = 2.1, p = 0.04) years.

f < 21 years vs. 21–30 (z = 3.7, p < 0.001), or 31–40 (z = 2.8, p = 0.005) years.

Participants appeared neither willing nor unwilling to donate stool in-centre at a stool bank or at home and delivering it, and mean willingness scores did not differ significantly (Table 2). Of those scoring ≥50 on willingness to donate in-centre (n = 212), 61% would donate weekly (24% daily, 7% monthly, 8% a set number of times). Participants willing to donate weekly (n = 129), would donate once (60%) or twice weekly (27%); and 73% would donate for 4 to 12 weeks. Similarly, of participants scoring ≥50 on willingness to donate at home (n = 215), 64% would donate weekly (31% daily, 4% monthly, 1% a set number of times). Those willing to donate weekly (n = 137) would do so once (36%), twice (31%), or three times (16%) weekly; and 72% would donate for 4 to 12 weeks. Table 2 shows participant characteristics by willingness to donate stool when location (in-centre, at home) and purpose for donating vary (loved one, research, new treatments). Willingness differed by blood and organ donor status, bowel habits, discomfort using public restrooms, awareness of CDI and FMT.

Table 2. Willingness to donate stool (0 not at all willing to 100 extremely willing) when location (in-centre to a stool bank, at home and deliver to a facility) and purpose (for a loved one, research, develop new treatment/s) are varied by participant characteristics (N = 397).

Willingness to donate stool Mean (SD)
Location Purpose
Characteristic Number of participants (%) In-centre (recipient unknown) At home & deliver (recipient unknown) Loved one* Research New treatments
All participants 52.43 (30.60) 52.05 (31.83) 85.19 (22.74) 59.18 (31.04) 61.97 (31.01)
At all willing (≥60 on scale) 180 (45%) 190 (48%) 354 (89%) 218 (55%) 238 (60%)
Highly willing (≥80 on scale) 105 (26%) 111 (28%) 306 (77%) 139 (35%) 159 (40%)
Gender
Male 208 (52.4) 53.04 (30.11) 50.07 (32.38) 85.39 (22.94) 57.93 (30.77) 62.27 (30.33)
Female 189 (47.6) 51.76 (31.20) 54.25 (31.16) 84.98 (22.57) 60.55 (31.37) 61.63 (31.83)
Between sub-group comparison p = 0.677 p = 0.192 p = 0.858 p = 0.402 p = 0.839
Age (years)
<21 62 (15.6) 45.14 (28.46) 42.45 (28.86) 80.63 (26.50) 49.02 (31.24) 53.39 (30.90)
21–30 185 (46.6) 53.32 (29.46) 54.15 (31.43) 85.22 (21.08) 59.83 (29.28) 63.17 (29.25)
31–40 98 (24.7) 54.58 (32.71) 52.31 (31.87) 88.47 (19.51) 63.01 (31.54) 65.38 (31.39)
41–50 39 (9.8) 52.79 (31.05) 55.26 (32.94) 83.87 (28.14) 61.67 (32.94) 60.87 (34.69)
>50 13 (3.3) 57.08 (37.93) 56.62 (42.50) 85.92 (29.77) 62.00 (39.05) 63.38 (38.60)
Between sub-group comparison p = 0.348 p = 0.130 p = 0.323 p = 0.72 p = 0.179
University education
No 149 (37.5) 49.40 (29.15) 48.24 (30.92) 84.30 (23.74) 55.82 (31.91) 59.45 (31.43)
Yes 248 (62.5) 54.25 (31.36) 54.35 (32.21) 85.73 (22.14) 61.20 (30.39) 63.48 (30.72)
Between sub-group comparison p = 0.127 p = 0.064 p = 0.542 p = 0.095 p = 0.210
Donated blood in the past year
No/Unsure 346 (87.2) 50.52 (30.81) 51.08 (32.36) 84.80 (23.07) 57.03 (31.40) 60.15 (31.47)
Yes 51 (12.8) 65.33 (25.95) 58.63 (27.40) 87.86 (20.31) 73.75 (24.09) 74.27 (24.68)
Between sub-group comparison p = 0.001 p = 0.114 p = 0.370 p < 0.001 p = 0.002
Registered organ donor
No/Unsure 271 (68.3) 48.30 (30.04) 48.26 (31.81) 83.87 (23.49) 54.19 (31.25) 57.42 (31.50)
Yes 126 (31.7) 61.32 (30.03) 60.18 (30.44) 88.03 (20.83) 69.90 (27.82) 71.75 (27.62)
Between sub-group comparison p < 0.001 p < 0.001 p = 0.090 p < 0.001 p < 0.001
Aware of CDI
No/Unsure 337 (84.9) 50.72 (30.54) 50.43 (32.09) 85.14 (22.62) 57.87 (30.99) 60.69 (31.13)
Yes 60 (15.1) 62.00 (29.40) 61.15 (28.90) 85.50 (23.56) 66.52 (30.55) 69.15 (29.58)
Between sub-group comparison p = 0.008 p = 0.016 p = .910 p = .047 p = .051
Aware of FMT
No/Unsure 205 (51.6) 46.21 (28.95) 46.60 (32.16) 83.01 (24.75) 52.55 (30.52) 55.66 (31.42)
Yes 192 (48.4) 59.06 (31.00) 57.85 (30.51) 87.53 (20.17) 66.26 (30.10) 68.70 (29.19)
Between sub-group comparison p < 0.001 p < 0.001 p = .048 p < 0.001 p < 0.001
Daily BM
No/Sometimes 81 (20.4) 47.38 (31.46) 44.21 (32.96) 74.75 (29.77) 49.98 (31.21) 52.84 (30.88)
Yes 316 (79.6) 53.72 (30.30) 54.07 (31.27) 87.87 (19.74) 61.54 (30.60) 64.31 (30.66)
Between sub-group comparison p = .096 p = 0.013 p < 0.001 p = 0.003 p = 0.003
Discomfort doing a BM in a public restroom
Discomfort none of the time (1) 125 (31.5) 60.19 (28.97) 55.42 (32.05) 87.66 (21.76) 67.11 (29.34) 69.66 (28.92)
Discomfort a little/some of the time (2) 190 (47.9) 52.54 (30.03) 52.23 (31.14) 85.16 (22.09) 57.14 (30.33) 60.01 (30.13)
Discomfort most/all of the time (3) 82 (20.7) 40.33 (30.80) 46.51 (32.69) 81.52 (25.31) 51.80 (32.93) 54.78 (33.94)
Between sub-group comparison overall p < 0.001 p = .143 p = .165 p = 0.001 p = 0.002
1 vs. 2 p = .068 p = 0.014 p = 0.018
1 vs. 3 p < 0.001 p = 0.001 p = 0.002
2 vs. 3 p = 0.006 p = .384 p = .399

BM = Bowel movement, CDI = Clostridioides difficile infection, FMT = Faecal microbiota transplantation. Bolded numbers indicate a statistically significant difference.

A Bonferroni correction of p < 0.01 for 3 or more comparisons was applied.

* Overall and in all sub-groups, participants were significantly more willing to donate stool to a loved one than for research or new treatments, all p’s < 0.01. There were no other differences within sub-groups by location or purpose.

Information needs rated as most important (≥6 on the 7-point scale) were convenience of donating (81%) and needing to travel to donate (80%). One-third had very positive attitudes towards donating stool in general and felt positively about personally donating. Table 3 displays participant’s information needs and attitudes towards donating stool. Information needs differed by gender, age group, and education, whereas general attitudes varied by gender and age, and personal attitudes by age.

Table 3. Participant’s information needs and attitudes by gender, age, and education (N = 397).

Gender Age (in years) University educated
Characteristic All Male Female <21 21–30 31–40 41–50 >50 No Yes
Information needs (1 not at all important to 7 very important)
Understanding the aim of donating stool. M (SD) 5.89 (1.42) 5.78 (1.49) 6.01 (1.32) 6.02 (1.31) 5.90 (1.39) 5.99 (1.16) 5.69 (1.75) 4.92 (2.40) 5.97 (1.37) 5.84 (1.44)
Between sub-group comparison p = 0.112 p = 0.098 p = 0.385
Understanding how donating stool could help you now or in the future. M (SD) 5.45 (1.52) 5.42 (1.49) 5.49 (1.56) 5.63 (1.43) 5.58 (1.47) 5.20 (1.41) 5.46 (1.86) 4.69 (2.10) 5.73 (1.34) 5.29 (1.60)
Between sub-group comparison p = 0.677 p = 0.092 p = 0.005
Understanding how donating stool could help patients now or in the future. M (SD) 5.96 (1.26) 5.85 (1.28) 6.09 (1.22) 6.13 (0.97) 6.01 (1.25) 5.92 (1.15) 5.92 (1.51) 4.92 (2.06)b 6.09 (1.12) 5.88 (1.33)
Between sub-group comparison p = 0.054 p = 0.033 p = 0.106
Receiving compensation for donating stool. M (SD) 4.62 (1.94) 4.77 (1.99) 4.45 (1.88) 4.77 (2.03) 4.86 (1.75) 4.50 (1.97) 4.00 (2.12) 3.08 (2.14)c 4.87 (1.99) 4.46 (1.89)
Between sub-group comparison p = 0.101 p = 0.003 p = 0.042
Out of pocket cost of donating stool, if any. M (SD) 5.42 (1.64) 5.31 (1.66) 5.53 (1.61) 5.77 (1.51) 5.48 (1.56) 5.34 (1.66) 4.95 (1.95) 4.77 (1.92) 5.68 (1.50) 5.25 (1.70)
Between sub-group comparison p = 0.170 p = 0.069 p = 0.011
How convenient donating stool would be in terms of logistics. M (SD) 6.28 (1.14) 6.23 (1.19) 6.35 (1.08) 6.06 (1.13) 6.30 (1.12) 6.41 (1.11) 6.31 (1.24) 6.08 (1.44) 6.13 (1.13) 6.37 (1.14)
Between sub-group comparison p = 0.283 p = 0.414 p = 0.041
Having to travel in order to donate stool. M (SD) 6.18 (1.24) 6.05 (1.36) 6.32 (1.07) 6.18 (0.95) 6.10 (1.32) 6.22 (1.30) 6.44 (0.94) 6.15 (1.52) 6.23 (1.13) 6.15 (1.30)
Between sub-group comparison p = 0.033 p = 0.643 p = 0.539
All information held about you at the stool bank is confidential. M (SD) 5.93 (1.57) 5.80 (1.66) 6.07 (1.45) 6.27 (1.18) 5.66d (1.73) 6.20 (1.35) 6.28 (1.28) 4.92e (2.02) 6.08 (1.45) 5.84 (1.63)
Between sub-group comparison p = 0.091 p = 0.001 p = 0.136
Understanding every step of the stool donation process before donating. M (SD) 5.77 (1.45) 5.69 (1.46) 5.85 (1.43) 6.11 (1.22) 5.64 (1.55) 5.78 (1.35) 6.05 (1.34) 5.08f (1.61) 6.01 (1.28) 5.62 (1.52)
Between sub-group comparison p = 0.273 p = 0.049 p = 0.009
Attitude–generally towards donating to a stool bank
Very positive. n (%) 118 (29.7) 58 (27.9) 60 (31.7) 22 (35.5) 46 (24.9) 27 (27.6) 18 (46.2)g 5 (38.5) 49 (32.9) 69 (27.8)
Positive, with reservations. n (%) 210 (52.9) 105 (50.5) 105 (55.6) 28 (45.2) 110 (59.5)h 55 (56.1) 13 (33.3) 4 (30.8) 72 (48.3) 138 (55.6)
Generally negative but realise it is necessary. n (%) 47 (11.8) 30 (14.4) 17 (9.0) 10 (16.1) 20 (10.8) 12 (12.2) 3 (7.7) 2 (15.4) 19 (12.8) 28 (11.3)
Negative. n (%) 11 (2.8) 10 (4.8)a 1 (0.5) 1 (1.6) 2 (1.1) 3 (3.1) 3 (7.7) 2 (15.4)i 4 (2.7) 7 (2.8)
No opinion. n (%) 11 (2.8) 5 (2.4) 6 (3.2) 1 (1.6) 7 (3.8) 1 (1.0) 2 (5.1) 0 (0.0) 5 (3.4) 6 (2.4)
Between sub-group comparison p = 0.037 p = 0.014 p = 0.696
Attitude–personally donating stool to a stool bank
Positive, would generally like to donate. n (%) 152 (38.3) 75 (36.1) 77 (40.7) 14 (22.6) 64 (34.6) 51 (52.0)j 17 (43.6) 6 (46.2) 48 (32.2) 104 (41.9)
Neutral, would depend on the situation. n (%) 206 (51.9) 111 (53.4) 95 (50.3) 41 (66.1)k 104 (56.2) 36 (36.7) 20 (51.3) 5 (38.5) 88 (59.1) 118 (47.6)
Negative, would generally not want to donate. n (%) 39 (9.8) 22 (10.6) 17 (9.0) 7 (11.3) 17 (9.2) 11 (11.2) 2 (5.1) 2 (15.4) 13 (8.7) 26 (10.5)
Between sub-group comparison p = 0.606 p = 0.012 p = 0.084

Bolded numbers indicate a statistically significant difference.

a male vs. female, z = 2.6, p = 0.009.

b >50 vs. < 21 years, p = 0.014. >50 vs. 31–40 years, p = 0.021.

c >50 vs. < 21 years, p = 0.031. >50 vs. 31–40 years, p = 0.010.

d 21–30 vs. 31–40 years, p = 0.041.

e >50 vs. < 21 years, p = 0.033. >50 vs.31-40 years, p = 0.039. >50 vs. 41–50, p = 0.047.

f >50 vs. < 21 years, p = 0.011.

g 41–50 vs. 21–30 (z = 2.7, p = 0.008) and 31–40 (z = 2.1, p = 0.04) years.

h 21–30 vs. < 21 (z = 2.0, p = 0.049), 41–50 (z = 3.00, p = 0.003), and >50 (z = 2.00, p = 0.043) years.

i >50 vs. < 21 (z = 2.3, p = 0.021), 21–30 (z = 3.5, p < 0.001), and 31–40 (z = 2.0, p < 0.045) years.

j 31–40 vs. < 21 (z = 3.7, p < 0.001) and 21–30 (z = 2.8, p = 0.005) years.

k < 21 vs. 31–40 years (z = 3.6, p < 0.001).

Table 4 presents hierarchical linear regressions of predictors of willingness to donate stool for a stool bank in-centre and at home. Participant characteristics, bowel habits, and knowledge of FMT were entered into the model at step 1, followed by information needs and attitude to personally donating stool in step 2. At the final model step, significant predictors of willingness to donate in-centre were less discomfort doing a BM in a public restroom, understanding how donating stool could help patients, less need to understand the donation process, and positive attitude towards personally donating (R2 = 0.45). For willingness to donate at home, understanding the personal benefits of donation and for patients, less need to understand the aim of donating stool, and positive attitudes towards personally donating were significant predictors at the final model step (R2 = 0.37). Participant characteristics were significant predictors initially but did not remain so once information needs and attitude were added.

Table 4. Hierarchical multiple regression analysis of the predictors of willingness to donate stool to a stool bank in-centre and at home and deliver (N = 397).

Willingness to donate stool in-centre Willingness to donate stool at home
Step 1 Step 2 Step 1 Step 2
Predictor B (95% CI) β B (95% CI) β B (95% CI) β B (95% CI) β
Gender (0 male, 1 female) -0.38 (-6.22, 5.45) -0.01 -2.32 (-7.14, 2.50) -0.04 4.18 (-2.07, 10.43) 0.07 1.23 (-4.11, 6.58) 0.02
Age in years -0.07 (-0.40, 0.25) -0.02 -0.15 (-0.42, 0.12) -0.05 0.12 (-0.23, 0.46) 0.03 0.03 (-0.27, 0.32) 0.01
University education (0 no, 1 yes) 3.05 (-3.07, 9.16) 0.05 1.58 (-3.52, 6.67) 0.03 3.65 (-2.90, 10.20) 0.06 3.76 (-1.89, 9.41) 0.06
Blood donor in the past year (0 no/unsure, 1 yes) 11.10 (2.36, 19.84) 0.12** 5.52 (-1.59, 12.62) 0.06 3.96 (-5.39, 13.32) 0.04 -1.73 (-9.60, 6.14) -0.02
Registered organ donor (0 no/unsure, 1 yes) 7.28 (0.61, 13.94) 0.11* 4.76 (-0.73, 10.25) 0.07 7.20 (0.07, 14.34) 0.11* 5.57 (-0.52, 11.65) 0.08
Daily BM (0 no/sometimes, 1 yes) 3.95 (-3.22, 11.13) 0.05 -1.71 (-7.63, 4.20) -0.02 8.65 (0.97, 16.33) 0.11* 2.75 (-3.80, 9.31) 0.04
Discomfort doing a BM in a public restroom (0 not at all to 5 all the time) -5.00 (-7.40, -2.60) -0.20*** -3.59 (-5.54, -1.63) -0.15*** -1.42 (-3.99, 1.15) -0.06 0.14 (-2.03, 2.31) 0.01
Heard of FMT prior to study (0 no, 1 yes) 7.97 (1.90, 14.04) 0.13** 2.92 (-2.21, 8.05) 0.05 7.33 (0.83, 13.83) 0.12* 3.37 (-2.32, 9.06) 0.05
Understanding the aim of donating stool -2.10 (-4.67, 0.47) -0.10 -4.26 (-7.11, -1.41) -0.19**
Understanding how donating stool could help you now or in the future 1.08 (-0.96, 3.12) 0.05 2.28 (0.02, 4.55) 0.11*
Understanding how donating stool could help patients now or in the future 3.58 (0.51, 6.66) 0.15* 6.10 (2.69, 9.50) 0.24***
Receiving compensation for donating stool 0.90 (-0.58, 2.37) 0.06 -0.07 (-1.70, 1.57) -0.00
Out of pocket cost of donating stool, if any 0.76 (-1.05, 2.56) 0.04 0.29 (1.72, 2.29) 0.02
How convenient donating stool would be in terms of logistics 0.01 (-2.60, 2.62) 0.00 -1.27 (-4.16, 1.63) -0.05
Having to travel in order to donate stool 0.31 (-1.91, 2.53) 0.01 2.23 (-0.24, 4.69) 0.09
All information held about you at the stool bank is confidential -0.50 (-2.25, 1.25) -0.03 -1.71 (-3.66, 0.23) -0.08
Understanding every step of the stool donation process before donating -2.68 (-4.73, -0.62) -0.13** -0.16 (-2.43, 2.12) -0.01
Attitude towards personally donating (0 neutral/negative, 1 positive) 35.45 (30.27, 40.63) 0.56*** 32.62 (26.88, 38.56) 0.50***
ΔR2 0.125 0.322 0.074 0.298
F change F (8, 388) = 6.92, p < 0.001 F (10, 378) = 2.02, p < 0.001 F (8, 387) = 3.88, p < 0.001 F (10, 377) = 17.93, p < 0.001

*** p < 0.001.

** p < 0.01.

* p < 0.05. Bolded numbers indicate a significant predictor.

BM = Bowel movement.

Willingness to donate stool in-centre, F(18, 378) = 16.98, p < 0.001. Willingness to donate stool at home, F(18, 377) = 12.44, p < 0.001.

Responses indicating the main reason(s) participants would consider donating stool were thematically analysed and two of seven motives identified were described by >10% of participants. The first main theme, altruism, reflected predominantly impure altruism with participant’s desire to help others generally, or specifically contribute to the recovery of those sick. The second main theme, compensation, focused predominantly on payment as either a primary or secondary motivator in addition to helping others. Table 5 details themes identified for motives and exemplar quotes.

Table 5. Themes identified in qualitative analysis of responses to motives (N = 391) and barriers for stool donation (N = 390).

Themes and sub-themes (n, % responses) Exemplar quotes
Motives (n = 483 responses)
Altruism (n = 295, 61%)
• Impure altruism (89%)
• Egalitarian warm glow (5%)
• Reciprocal altruism (3%)
• Reluctant altruism (3%)
“It would be a great feeling knowing that something I did saved someone's life. Much like how blood donations save lives, so do stool donations.”
“Feeling like I am able to help someone with a condition that may be serious and or life-threatening. Feeling as though I can "make a difference" and improve the quality of someone else's life.”
“I donate blood and plasma regularly. It is my way of helping the world how I can. I can’t change big things, but things like this, is within my control. I can’t help every suffering person, but I can make a difference to one. Same with this.”
“Giving back to the community/leaving a positive influence on society.”
“Who knows what health conditions I might have in the future and need medical help. Where I’m healthy I hope I can help. The biggest motivation I have to help would be if a family member has been afflicted with this disease or a very close friend.”
“To help someone in need knowing that I may be able to save a life if there is a shortage of people willing to donate.”
Compensation (n = 65, 13.5%) “Financial. Sorry but the combination of embarrassment and time spent being healthy and delivery of the stool has to make up for lost time.”
“To relieve the suffering of others and give back to the community. As a secondary reason, I would also be motivated by compensation, such as drinks and snacks offered to me after the donation.”
“Financial reasons would certainly enhance the likelihood of donation but if there was a sound enough reason—helping others—and an easy anonymous process that would help.”
Benefits to recipients outweigh the cost of donating (n = 44, 9%) “Because it's essentially a non-invasive procedure that doesn't cost me anything so why wouldn't I want to help someone if I can?”
“To be honest, other than logistics (such as location) I cannot find many reasons not to. If my stool, that otherwise would go to waste could potentially have positive health benefits for another person, or contribute to research to ensure well-being of others, then that would be enough of a reason for me.”
Helping science (n = 33, 7%) “I would be donating to assist in treating their key health issues and hope that my sample would also be used in developing alternate treatments (research).”
“I believe that participating in research is very important, to help other people and also to advance research. Also hopefully reduces stigma around topics such as this one, normalises the concept to those around me.”
Greater awareness of CDI and FMT (n = 18, 4%) “Help others. Success rate is important i.e. we know organ donation and blood donation saves lives but does this. More emphasis on success rate is important.”
“Compensation would be motivating, but also the understanding of just HOW helpful it could potentially be.”
Donation is convenient and logistically feasible (n = 17, 3.5%) “Easy to do the donation within the acceptable range of transportation.”
“If it were easy to do, I'd decide to do it because it would help someone in need and depending on the circumstances could potentially save a life. Receiving compensation would be another big motivator. But as long as the process was easy and preferably fairly quick to fulfil, I'd be quite motivated to do it as I am a lazy/impatient person.”
Personal involvement (n = 11, 2%) “I believe it would help a lot to have knowledge of this disease and to have some kind of experience with it (e.g., a family member or friend) as this usually give more insight into the issues and makes people more willing to donate.”
Barriers (n = 481 responses)
Logistics (n = 192, 39.9%)
• Having to travel to donate (47%)
• General inconvenience (15%)
• Lack of flexibility in scheduling or donation requirements (28%)
• Lengthy donation process (8%)
• Out of pocket costs (2%)
“The high frequency required (compared to blood donation which is once every three months) and the location of a donation centre (if it wasn't convenient).”
“If I had to do it too often, making it a chore, or if the method of donation were inefficient and a bit of a commute. Also, if I had to pay the express postage myself, I think I would be much less likely to continue with my service.”
“If I had to provide the stool at the stool bank itself instead of doing so from home and then delivering it. Or if the requirements for donating were too strict it would become difficult, e.g. 6–7 times a week would be too hard or maybe tiring to have to deliver each time.”
“If I cannot batch the stool delivery with other activities I do in the day and have to specifically go out to do it.”
Concerns about capabilities (n = 83, 17.3%)
• Difficult/complicated process (51%)
• Co-ordinating time of BMs (15%)
• Health/quality of sample (28%)
• Fear of needles/blood tests (6%)
“The process and whether it is an easy process to donate and send it off.”
“Long complicated or too frequent communications. Long wait times or complicated way of delivering the sample.”
“It’s not something I can time or know when it’s going to happen as such so it isn’t like a doctor’s appointment or blood donation where you know when you turn up it is going to be able to take place.”
“Giving blood. I understand that's part of the process but needles are a huge no no for me.”
Disgust (n = 80, 16.6%)
• Disgust at the thought of donating stool (14%)
• Disgust at having to collect stool (32.5%)
• Unhygienic conditions (38%)
• Disgust at transporting/delivering stool (16%)
“The idea of putting my stool in another humans body—no matter the benefit, it’s hard to digest.”
“If the process involves me having to poop into a container and I accidentally touch my poooo:(((”
“Public-type restroom or otherwise uncomfortable facilities.”
“The process of getting it to the stool bank—where is it?? If it's in/near the hospital here I have to drive in, pay for parking, and carry crap through the busy streets. Imagine people without cars doing this too. It's just very weird. I'd like to know more about the containers. The lid coming off in a backpack would be a disaster.”
Discomfort (n = 78, 16.2%)
• Lack of anonymity or privacy (47%)
• Embarrassment (40%)
• Discomfort doing a BM in a public facility (13%)
“If I would meet face to face the people who would examine my stool.”
“Everybody knowing what I'm doing. Discreet way would be better to manage.”
“Embarrassment. Friends or family if they were to know about it being embarrassed of me, or I of myself during any part of the process.”
“The handling of the stool and having to discuss the process with others who may not understand/judge the reason for the donation.”
“I would not want to donate stool I produced in a public bathroom, even one at the stool bank itself. I would far prefer being able to poop at home and bring it in that way.”
Availability (n = 41; 8.5%) “The difficulties are largely practical, to do with how to access the donation places and manage to do it without major disruptions to my work schedule.”
“Not being able to fit it in around work and picking up the kids from school.”
Lack of compensation (n = 7; 1.5%) “If it was hard to donate and I had to go out of my way to do it for no reward.”

CDI = Clostridioides difficile infection.

Responses detailing factors that would make it difficult or stop participants from donating were thematically analysed and four of six barriers identified were described by >10% of participants (Table 5). The main barrier, logistics, captured inconvenience generally and specifically related to travel for donation purposes, and lack of flexibility in scheduling/donation requirements. The second barrier, concerns about capabilities, reflected participant’s apprehension that the process would be too difficult or complicated, or they would be unable to successfully complete it. The third and fourth barriers, disgust and discomfort, comprised participant’s feelings of revulsion or embarrassment, and concerns about donating, collecting, and transporting/delivering stool.

Discussion

Participants in this study appeared uncertain about donating stool in-centre and at home, with <30% highly willing to donate in either context; a finding which differs markedly from prior research that suggested strong willingness to donate [12]. Of those expressing some willingness to donate, once or twice weekly donations were preferred over one- to three-month periods. Barriers noted in the current study indicate less willingness when the required donation frequency is high or the duration lengthy [8,12,13]. While acknowledging the need to minimise costs associated with donors, this finding suggests that in the longer term it may be advantageous to recruit more donors for less intensive regimes.

Contributors to willingness to donate stool in-centre and at home included the need to understand how donating stool could help patients now or in the future and having positive attitudes towards personally donating stool. In addition, potential in-centre donors who had less need to understand every step of the donation process (suggesting trust or awareness of the process), and experienced less discomfort doing a BM in a public restroom were more willing to donate. Potential donors who attributed higher importance to knowing how stool donation could personally benefit them, and had less need to understand the aim of donating stool, were more willing to donate stool at home. Addressing potential donor’s information needs, minimising discomfort for donors in-centre, and promoting positive attitudes toward personally donating stool appear key to encourage willing donors.

As with prior research [9,11,12], those who were aware of FMT and were blood donors or registered organ donors were more willing to donate stool. However, this association was specific to the donation setting with blood donors more willing to donate stool in-centre, and those aware of FMT and registered organ donors more willing to donate in both contexts. Contrasting with prior research [12], participant characteristics did not significantly contribute to willingness when other factors were considered.

Most participants reported regular BMs, although there were discrepancies in reports of BM frequency [20,23,24], with 58% reporting one BM daily, but only 28% reporting seven BMs weekly (Table 1). This finding suggests that potential donors may be inaccurate in their estimates. Other studies have similarly noted a discrepancy in daily BMs reported depending on the measure used to assess BM frequency [20,23,24]. For example, Lewis and Heaton [23] reported that most participants had a BM once daily. However, when calculations were based on reported weekly frequency, only a third had a daily BM (women 36%, men 38%). Further, when the interval between BMs was considered (range 22 to 27 hours), approximately half on average had a daily BM interval (46.5% women, 50.7% men). Therefore, universal stool banks with preferences for intensive donation regimes should consider asking potential donors to keep a diary of their bowel habits prior to in-person screening.

BMs occurred most often in the morning and took <5 minutes. Two-thirds experienced some discomfort having BMs in public restrooms, and qualitative responses also showed concerns about lack of privacy and hygiene. No gender or age differences in regularity or frequency of BMs emerged [cf. 21–23,25], although females were more likely to have morning BMs, take less time to complete BMs, and experience greater discomfort having BMs in public restrooms [27]. Younger participants were least likely to have morning BMs and most likely to have BMs in the evening or at night. For in-centre collectors, targeting specific demographic groups to donate at non-peak times (e.g., women early in the morning; younger ages in the evening) may be feasible. Potential donors should also be screened early on in recruitment regarding their discomfort having BMs in public facilities. Recruitment materials should emphasise privacy and hygiene measures implemented in collection facilities to reassure potential donors.

Prominent information needs focused on convenience of stool donation and travel required in order to donate. Information needs also differed by gender, age, and education. For instance, convenience was of greater concern for university educated participants, and travel requirements were more important for females. These information needs align with logistics (e.g., travel, donation requirements, flexibility) and concerns about capabilities to donate as the main barriers identified to stool donation by our sample, and also concur with prior research [12,1416]. Targeting donor recruitment efforts in locations close to stool banks, clinics or collection facilities would minimise inconvenience and improve logistics. Tying stool donation to another donation type (e.g., blood donation) [43], or another activity that is an established part of a donor’s routine (e.g., workplace donor programs) may also decrease barriers. Potential donors should be provided with a ‘donor journey map’ at an early stage to build their confidence, and provide reassurance that donors have limited interaction with their donation and staff in-centre, once they have donated.

Altruism, most often helping others generally or those specifically with CDI, was identified as the main reason participants would consider donating. This theme is consistent with prior research [9,12], as is the finding in this study that understanding how stool donation could help patients was a significant positive predictor of willingness to donate. Financial compensation was a motivator of lesser importance, and something that would reinforce participant’s primary helping motivation. Donor recruitment materials should emphasise how stool donation helps patients and incorporate messages highlighting the large benefit to recipients versus small cost to donors ratio and helping to advance science.

Strengths of this study include the perspective of potential donors in Australia where stool banks and the need for community donors are rapidly developing [44,45]. It provides information not currently available on potential donors’ bowel habits, discomfort donating outside the home environment, and information needs. It extends research on engaging people in this form of donation which compared to blood and organ donation is relatively novel, with little information available. This study is limited by the potential for participants who were already interested and motivated to donate stool to have self-selected to participate. Further, information about participant’s occupation or location was not collected, preventing a consideration of the influence of these characteristics on willingness to donate. It is possible that participants in this study appeared less willing to donate than the previous Canadian study [12] due to this latter study including participants who were university-affiliated health professionals and thus potentially more willing to donate. Moreover, there is the potential for differences in willingness to donate stool based on region (e.g., urban vs. rural) or country-specific delivery of healthcare systems (e.g., public and private, non-profit and for-profit) and the perceived or actual costs for donors. Country-specific differences in protocols (e.g., age, facilities) and changes in terminology and processes due to advances in automated facilities (e.g., washed microbiota transplantation vs. manual faecal microbiota transplantation [19]) may also impact willingness and acceptability of stool donation. This study is cross-sectional, and therefore limited by its focus on willingness to donate, rather than donor behaviour. Although study eligibility criteria mirrors that used broadly for community donors to stool banks, we relied on self-report rather than objective measures. Finally, although the contributors examined in this study explained a significant proportion of variance in willingness to donate, the variance left unexplained suggests other unidentified factors may inform potential donors’ willingness and these require further exploration.

In conclusion, this study revealed that most Australian community members are uncertain about donating stool. This study identified the importance of and need to consider bowel habits, level of comfort donating in-centre, and potential donor’s information needs as early as possible in the recruitment and screening process to optimise their willingness to donate. Results also confirm that in order to increase the numbers of willing donors, it is critical for universal stool banks and FMT programs to examine logistics associated with recruitment and donation processes and implement strategies that increase flexibility, feasibility, and comprehensibility for potential donors who are constrained by time, knowledge deficits, and limited access to stool banks and facilities.

Supporting information

S1 Appendix. Pre-screening and main surveys.

(DOCX)

S2 Appendix. Information presented to participants about CDI, FMT, and stool donation.

(DOCX)

Acknowledgments

We acknowledge Abby Edwards for assistance with data collection and coding. Australian governments fund Australian Red Cross Lifeblood for the provision of blood, blood products, and services to the Australian community.

Data Availability

All data and supporting information files are available from the Open Science Framework database (https://osf.io/mdwfc/).

Funding Statement

The authors received funding from The University of Queensland Vice-Chancellor’s Strategic Funds (BM) and internal funds granted by The University of Queensland School of Psychology (MH) to collect data using a paid participant panel and to employ a research assistant to assist with data collection and coding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional internal or external funding received for this study.

References

  • 1.Allegretti JR, Mullish BH, Kelly C, Fischer M. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. The Lancet. 2019;394(10196):420–431. 10.1016/S0140-6736(19)31266-8 [DOI] [PubMed] [Google Scholar]
  • 2.Costello SP, Soo W, Bryant RV, Jairath V, Hart AL, Andrews JM. Systematic review with meta‐analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 2017. August;46(3):213–24. 10.1111/apt.14173 [DOI] [PubMed] [Google Scholar]
  • 3.König J, Siebenhaar A, Högenauer C, Arkkila P, Nieuwdorp M, Norén T, et al. Consensus report: faecal microbiota transfer–clinical applications and procedures. Alimentary Pharmacology & Therapeutics. 2017. January;45(2):222–39. 10.1111/apt.13868 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Turse EP, Dailey FE, Ghouri YA, Tahan V. Fecal microbiota transplantation donation: the gift that keeps on giving. Current opinion in pharmacology. 2019. December 1;49:24–8. 10.1016/j.coph.2019.04.009 [DOI] [PubMed] [Google Scholar]
  • 5.Dehlholm-Lambertsen E, Hall BK, Jørgensen SM, Jørgensen CW, Jensen ME, Larsen S, et al. Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection. Therapeutic advances in gastroenterology. 2019. April;12: 10.1177/1756284819843002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Merlo G, Graves N, Brain D, Connelly LB. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia. Journal of Gastroenterology and Hepatology. 2016;31:1927–1932. 10.1111/jgh.13402 [DOI] [PubMed] [Google Scholar]
  • 7.Edelstein C, Daw JR, Kassam Z. Seeking safe stool: Canada needs a universal donor model. CMAJ. 2016;188(17–18):E431–2. 10.1503/cmaj.150672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hota SS, McNamara I, Jin R, Kissoon M, Singh S, Poutanen SM. Challenges establishing a multi-purpose fecal microbiota transplantation stool donor program in Toronto, Canada. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2019:1–9. 10.3138/jammi.2019-0003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tariq R, Weatherly R, Kammer P, Pardi DS, Khanna S. Donor screening experience for fecal microbiota transplantation in patients with recurrent C. difficile infection. Journal of Clinical Gastroenterology. 2018;52(2):146–150. 10.1097/MCG.0000000000000768 [DOI] [PubMed] [Google Scholar]
  • 10.Ling K, Ramakrishna B, Stoltzner Z, Kassam Z, Osman M, Panchal P. Stool donor demographics and performance indicators: evidence from 223 enrolled stool donors: 2878. American Journal of Gastroenterology. 2018;113:S1590. [Abstract]. [Google Scholar]
  • 11.Wu X, Dai M, Buch H, Bai J, Long W, Long C, et al. The recognition and attitudes of postgraduate medical students toward fecal microbiota transplantation: a questionnaire study. Therapeutic Advances in Gastroenterology. 2019; 10.1177/1756284819869144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.McSweeney B, Allegretti JR, Fischer M, Xu H, Goodman KJ, Monaghan T, et al. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation. Gut Microbes. 2020. January 2;11(1):51–62. 10.1080/19490976.2019.1611153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Paramsothy S, Borody TJ, Lin E, Finlayson S, Walsh AJ, Samuel D, et al. Donor recruitment for fecal microbiota transplantation. Inflammatory Bowel Diseases. 2015;21(7):1600–1606. 10.1097/MIB.0000000000000405 [DOI] [PubMed] [Google Scholar]
  • 14.Burns LJ, Dubois N, Smith MB, Mendolia GM, Burgess J, Edelstein C, et al. 499 donor recruitment and eligibility for fecal microbiota transplantation: results from an international public stool bank. Gastroenterology. 2015;148(4):S-96 [Abstract]. 10.1016/S0016-5085(15)30331-0 [DOI] [Google Scholar]
  • 15.Dubois N, Ling K, Osman M, Burns L, Mendolia G, Blackler D, et al. Prospective assessment of donor eligibility for fecal microbiota transplantation at a public stool bank: results from the evaluation of 1387 candidate donors. Open Forum Infectious Diseases. 2015;2(suppl. 1). [Abstract]. 10.1093/ofid/ofv133.678 [DOI] [Google Scholar]
  • 16.Kassam Z, Dubois NE, Ling K, Ramakrishna B, Qazi T, Allegretti JR, et al. 512–Donor Health Screening for Fecal Microbiota Transplantation: Prospective Evaluation of 15,317 Candidate Donors. Gastroenterology. 2019;156(6):S-100 [Abstract]. 10.1016/S0016-5085(19)37042-8 [DOI] [Google Scholar]
  • 17.Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019;68(12):2111–2121. 10.1136/gutjnl-2019-319548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Terveer EM, Vendrik KE, Ooijevaar RE, Lingen EV, Boeije-Koppenol E, Nood EV, et al. Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank. United European Gastroenterology Journal. 2020. September 29 10.1177/2050640620957765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fecal Microbiota Transplantation-standardization Study Group. Nanjing consensus on methodology of washed microbiota transplantation. Chinese Medical Journal. 2020;133(19):2330–2332. 10.1097/CM9.0000000000000954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Rendtorff RC, Kashgarian M. Stool patterns of healthy adult males. Diseases of the Colon & Rectum. 1967. May 1;10(3):222–8. 10.1007/BF02617184 [DOI] [PubMed] [Google Scholar]
  • 21.Sanjoaquin MA, Appleby PN, Spencer EA, Key TJ. Nutrition and lifestyle in relation to bowel movement frequency: a cross-sectional study of 20 630 men and women in EPIC–Oxford. Public Health Nutrition. 2004. February;7(1):77–83. 10.1079/phn2003522 [DOI] [PubMed] [Google Scholar]
  • 22.Everhart JE, Go VL, Johannes RS, Fitzsimmons SC, Roth HP, White LR. A longitudinal survey of self-reported bowel habits in the United States. Digestive diseases and sciences. 1989. August 1;34(8):1153–62. 10.1007/BF01537261 [DOI] [PubMed] [Google Scholar]
  • 23.Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology. 1997; 32(9):920–924. 10.3109/00365529709011203 [DOI] [PubMed] [Google Scholar]
  • 24.Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. Bowel habit in relation to age and gender: findings from the National Health Interview Survey and clinical implications. Archives of internal medicine. 1996;156(3):315–20. 10.1001/archinte.1996.00440030117014 [DOI] [PubMed] [Google Scholar]
  • 25.Zuckerman MJ, Guerra LG, Drossman DA, Foland JA, Gregory GG. Comparison of bowel patterns in Hispanics and non-Hispanic whites. Digestive diseases and sciences. 1995;40(8):1763–9. 10.1007/BF02212699 [DOI] [PubMed] [Google Scholar]
  • 26.Raybardhan S, Ng W, Tomassi J, Katz K. Self-stool banking as a source for fecal microbiota transplantation: A pilot study. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2017;2(1):9–14. 10.3138/jammi.2.1.002 [DOI] [Google Scholar]
  • 27.American Gut Health Check Survey. 2018. Available https://www.healthline.com/health/american-gut-check#3 [Retrieved 27th November, 2019].
  • 28.Australian Government, Department of Health. Therapeutic Goods Administration. (2019). Draft standards for faecal microbiota transplant (FMT) products Consultation paper version 1.0, November 2019. Subsection 7 age limits. Retrieved 28th October 2020. https://www.tga.gov.au/sites/default/files/consultation-draft-standards-faecal-microbiota-transplant-fmt-products.pdf.
  • 29.Australian Government, Department of Health. Therapeutic Goods Administration. (2020). Therapeutic Goods (Standard for Faecal Microbiota Transplant Products) (TGO 105) Order 2020. Retrieved 28th October 2020. https://www.legislation.gov.au/Details/F2020L01011/d113c4fe-362b-444f-a4e3-d0e0a330e428.
  • 30.Hyde MK, Masser BM. Eligible blood donors’ decisions about donating stool for fecal microbiota transplantation: Does ambivalence play a role? Transfusion. 2020. October 1 10.1111/trf.16109 [DOI] [PubMed] [Google Scholar]
  • 31.Van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. New England Journal of Medicine. 2013. January 31;368(5):407–15. 10.1056/NEJMoa1205037 [DOI] [PubMed] [Google Scholar]
  • 32.Rode AA, Bytzer P, Pedersen OB, Engberg J. Establishing a donor stool bank for faecal microbiota transplantation: methods and feasibility. European Journal of Clinical Microbiology & Infectious Diseases. 2019;38(10):1837–1847. 10.1007/s10096-019-03615-x [DOI] [PubMed] [Google Scholar]
  • 33.Knowles SR, Skues J. Development and validation of the Shy Bladder and Bowel Scale (SBBS). Cognitive Behaviour Therapy. 2016;45(4):324–338. 10.1080/16506073.2016.1178800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.US Department of Health and Human Services Centers for Disease Control and Prevention. (2019). Clostridioides difficile (C. diff). Available cdc.gov/cdiff [Retrieved 10th January, 2020].
  • 35.American College of Physicians. (2019). Clostridium difficile infection. Available https://www.acponline.org/practice-resources/patient-education/online-resources/clostridium-difficile-infection [Retrieved 10th January, 2020].
  • 36.NHS University of Southampton. (2017). Patient information factsheet Clostridium difficile. Available https://www.uhs.nhs.uk/Media/UHS-website-2019/Patientinformation/Stayinginhospital/Clostridiumdifficlepatientinformation.pdf [Retrieved 10th January, 2020].
  • 37.Open Biome. (2019). About FMT. Available https://www.openbiome.org/safety [Retrieved 10th January, 2020].
  • 38.Costello SP, Bryant RV. Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Internal Medicine Journal. 2019;49:148–151. 10.1111/imj.14212 [DOI] [PubMed] [Google Scholar]
  • 39.Centre for Digestive Diseases. (2016). Faecal Microbiota Transplantation. Available https://centrefordigestivediseases.com/faecal-microbiota-transplantation/ [Retrieved 10th January, 2020].
  • 40.Arnetz J, Sudan S, Goetz C, Arnetz B, Gowland L, Manji S, et al. Preliminary development of a questionnaire measuring patient views of participation in clinical trials. BMC Research Notes. 2019;12(1):667 10.1186/s13104-019-4724-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Jones CW, Braz VA, McBride SM, Roberts BW, Platts-Mills TF. Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter? BMJ Open. 2016;6(11):e013649 10.1136/bmjopen-2016-013649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3:77–101. 10.1191/1478088706qp063oa 32100154 [DOI] [Google Scholar]
  • 43.Jørgensen SMD, Erikstrup C, Dinh KM, Lemming LE, Dahlerup JF, Hvas CL. Recruitment of feces donors among blood donors: Results from an observational cohort study. Gut Microbes. 2018;9(6):540–550. 10.1080/19490976.2018.1458179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Krishnan S. (9th March, 2020). Australia's first public stool bank is paying people to donate their poo for faecal transplants. ABC News. Available https://www.abc.net.au/news/2020-03-09/first-public-poo-bank-in-adelaide/12034138 [Retrieved 7th May, 2020].
  • 45.Australian Red Cross Lifeblood. (9th September, 2019). WA to host life-changing clinical trial. Available https://m.donateblood.com.au/media/news/wa-host-life-changing-clinical-trial [Retrieved 10th September, 2019].

Decision Letter 0

Rick K Wilson

5 Oct 2020

PONE-D-20-21058

Determinants of community member’s willingness to donate stool for faecal microbiota transplantation

PLOS ONE

Dear Dr. Hyde,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I agree with the reviewers concerning this manuscript. They each raise relatively minor points and those points are aimed at clarifying the design and analysis of the data. As such, it should be relatively straightforward to address their concerns.

I look forward to a revision.

Please submit your revised manuscript by Nov 19 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Rick K. Wilson, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

3.  Thank you for stating in your Funding Statement:

"This work was funded in part by an award made from The University of Queensland (UQ) Vice-Chancellor’s Strategic Funds (BM) and internal funds granted by the UQ School of Psychology (MH). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.".

i) Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

ii) Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Hyde and Masser present a large survey of factors influencing participation as a stool donor for FMT from Australia. They explore participant demographics, bowel habit, factors that may attract or deter donors, and motivators to donation, exploring these quantitatively and qualitatively. They discuss how knowledge of these push and pull factors can be applied in clinical practice by stool banks to influence their policies regarding donor recruitment and retention.

I have very little concerns with the study design, the analysis, the presentation of data and the interpretation – these are all great. There are just a few smaller factors that I think are also worthy of consideration/ amendment:

-Title – I think should be members’ rather than member’s.

-Consistency required with spelling, e.g. ‘faecal’ in title but ‘fecal’ in abstract.

-Could you explain a little more about how people were recruited to take the survey? It is important to have this information to give more insight into the population completing it, and any potential biases in participant recruitment.

-Was any information recorded about work of participants? It would be interesting to see if a connection to healthcare influenced outlook about this.

-I am not sure that any data is provided regarding where in Australia that participants came from. It might at least be interesting to know if there was any difference in outlook between people in smaller/ more rural communities from larger/ urban connurbations? Where differences exist between outcome in this study compared to previous studies from other countries/ regions – could the investigators propose any country-specific regions why these might differ, e.g. aspects related to the delivery of healthcare systems?

Reviewer #2: This research titled “Determinants of community member’s willingness to donate stool for fecal microbiota transplantation” has the merit to represent the first study of the Australian community’s willingness to donate stool. This study offers some good suggestions for stool banks to increase the numbers of willing donors. Comments:

1.This is an interesting and practical survey on potential donors’ attitudes and willingness to FMT. This mainly reflected the situation in Australia. However, the methods and protocol on donor screening in the global varies a lot in different areas or countries. I suggest authors to discuss and the latest consensus report from the FMT-standardization study group. The recommended donor population is younger than the mean age of investigated population in the current study. Importantly, the location for collecting stool is only in the specific room within the FMT center. This is the biosafety requirement according to the consensus. At least this is very important for FMT center. I suggest discuss the direction and different choices under the different regulations. Readers of the journal should know the general view on the donor screening and related laboratory process.

Fecal Microbiota Transplantation-standardization Study Group. Nanjing consensus on methodology of washed microbiota transplantation [published online ahead of print, 2020 Jul 21]. Chin Med J (Engl). 2020;10.1097/CM9.0000000000000954. doi:10.1097/CM9.0000000000000954

2.Line 116 - Information presented to participants about CDI and FMT was particularly important. I would kindly ask the authors to provide the detailed short paragraphs describing CDI and FMT (even as Supplementary material).

3.Question about Table 1 - The data of BMs daily frequency <1 and BMs weekly frequency <7 are inconsistent, which you explained in the discussion section may be due to inaccurate assessment of participants. This raises questions about the reliability of the questionnaire data.

4.Line 178 - Can the author describe the scoring rules for willingness to donate stool in detail?

5. According to the latest report, FMT has been named washed microbiota transplantation (WMT) based on the latest technology. Participants may make different choices after learning about these new developments. You can add these to the discussion section.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 10;15(12):e0243751. doi: 10.1371/journal.pone.0243751.r002

Author response to Decision Letter 0


11 Nov 2020

Dear Professor Wilson and Reviewers,

Thank you very much for the feedback and for the opportunity to undertake revisions. We appreciate the useful suggestions from the reviewers and have endeavoured to incorporate these where possible. Our responses to reviewer feedback are below. Changes to the manuscript are identified using track changes.

Please note as per our cover letter, since our original PLOS ONE submission we subsequently published an article in Transfusion that used a subset of participants to explore a wholly different focus on the role of ambivalence in decisions about stool donation and used an independent set of variables. We have noted the link to the Transfusion paper in the text of our revised PLOS ONE manuscript on p. 6.

We have separately addressed in our cover letter the additional journal requirements outlined in the manuscript decision letter.

Thank you once again for considering our manuscript and we look forward to hearing from you.

Yours sincerely,

The Authors

REVIEWER 1

Feedback: I have very little concerns with the study design, the analysis, the presentation of data and the interpretation – these are all great.

Response: Thank you very much for your kind evaluation of our work.

Feedback: There are just a few smaller factors that I think are also worthy of consideration/ amendment:

a) Title – I think should be members’ rather than member’s.

Response: a) Thank you, the title has now been corrected.

Feedback: b) Consistency required with spelling, e.g. ‘faecal’ in title but ‘fecal’ in abstract.

Response: b) Our apologies for the error and thank you for noting. We have now ensured all spelling is consistent.

Feedback: c) Could you explain a little more about how people were recruited to take the survey? It is important to have this information to give more insight into the population completing it, and any potential biases in participant recruitment.

Response: c) Thank you for this suggestion. We have added further information in the Method and Materials section on p. 5 and p. 6 about how we recruited participants to do the survey. Specifically, we have noted the approximate number of Australians who were active on the system, the proportion of men, and that participants self-selected into the study and completed a pre-screening survey to confirm their eligibility before being invited to complete the main survey. Pre-screening questions have also been included as Supplementary Information (S1 Appendix).

Feedback: d) Was any information recorded about work of participants? It would be interesting to see if a connection to healthcare influenced outlook about this.

Response: d) We agree this information would be interesting to have. Unfortunately, we did not ask participants about their occupation and we have now noted this as a limitation on p. 35.

Feedback: e) I am not sure that any data is provided regarding where in Australia that participants came from. It might at least be interesting to know if there was any difference in outlook between people in smaller/ more rural communities from larger/urban connurbations? Where differences exist between outcome in this study compared to previous studies from other countries/ regions – could the investigators propose any country-specific regions why these might differ, e.g. aspects related to the delivery of healthcare systems?

Response: e) Thank you for this suggestion. We agree it would be interesting to explore this aspect. Unfortunately, we did not collect data about location, however we have included this as a limitation based on the potential for differences across region or countries on p. 35.

REVIEWER 2

Feedback: This is an interesting and practical survey on potential donors’ attitudes and willingness to FMT.

Response: Thank you, we appreciate your kind evaluation of our work.

Feedback: 1) This mainly reflected the situation in Australia. However, the methods and protocol on donor screening in the global varies a lot in different areas or countries. I suggest authors to discuss and the latest consensus report from the FMT-standardization study group. The recommended donor population is younger than the mean age of investigated population in the current study. Importantly, the location for collecting stool is only in the specific room within the FMT center. This is the biosafety requirement according to the consensus. At least this is very important for FMT center. I suggest discuss the direction and different choices under the different regulations. Readers of the journal should know the general view on the donor screening and related laboratory process.

Response: 1) Thank you for raising this important point. We have now included discussion that screening criteria and protocols vary globally and have included an example of this with references to protocols including the suggested Nanjing consensus from the FMT-standardization Study Group on p. 5-6.

We have also included information that there is variability in stool collection procedures so that readers are aware and noted that this variability in process may impact willingness and acceptability of donation (p. 4 and p. 35)

Feedback: 2) Line 116 - Information presented to participants about CDI and FMT was particularly important. I would kindly ask the authors to provide the detailed short paragraphs describing CDI and FMT (even as Supplementary material).

Response: 2) On the Reviewer’s advice, we have now provided the detailed short paragraphs about CDI and FMT as Supplementary Information (S2 Appendix).

Feedback: 3) Question about Table 1 - The data of BMs daily frequency <1 and BMs weekly frequency <7 are inconsistent, which you explained in the discussion section may be due to inaccurate assessment of participants. This raises questions about the reliability of the questionnaire data.

Response: 3) Thank you for raising this point. We have now further explained that this inaccuracy in estimating weekly BMs is not unique to our study and has occurred and been noted in prior research (p. 33). It was our knowledge of this research that prompted us to include multiple assessments so readers could obtain a fuller picture about the bowel habits of participants.

Feedback: 4) Line 178 - Can the author describe the scoring rules for willingness to donate stool in detail?

Response: 4) We have included further detail about the scoring of willingness on p. 7.

Feedback: 5) According to the latest report, FMT has been named washed microbiota transplantation (WMT) based on the latest technology. Participants may make different choices after learning about these new developments. You can add these to the discussion section.

Response: 5) 5. Thank you for this suggestion. We have now noted the following in the Discussion on p. 35:

“Country-specific differences in protocols (e.g., age, facilities) and changes in terminology and processes due to advances in automated facilities (e.g., washed microbiota transplantation vs. manual faecal microbiota transplantation [19]) may also impact willingness and acceptability of stool donation.”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Rick K Wilson

26 Nov 2020

Determinants of community members' willingness to donate stool for faecal microbiota transplantation

PONE-D-20-21058R1

Dear Dr. Hyde,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

I want to thank you for being so responsive to the reviewers. I think that the manuscript now reads much better and clarifies minor concerns held by the reviewers. I see no reason to ask the reviewers to comment further on the revision.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Rick K. Wilson, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Rick K Wilson

2 Dec 2020

PONE-D-20-21058R1

Determinants of community members’ willingness to donate stool for faecal microbiota transplantation

Dear Dr. Hyde:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Rick K. Wilson

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Pre-screening and main surveys.

    (DOCX)

    S2 Appendix. Information presented to participants about CDI, FMT, and stool donation.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All data and supporting information files are available from the Open Science Framework database (https://osf.io/mdwfc/).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES